July 2, 2018

CMIC HOLDINGS Co., Ltd. (hereafter”CMIC”) hereby announces that, in relation to the issuance of new shares through third-party allotment as detailed by the “Announcement of Capital and Business Tie-up in CDMO Business between CMIC HOLDINGS Co., Ltd. and Development Bank of Japan Inc. (hereafter”DBJ”)” issued on March 30, 2018, the procedures of payment for the shares were completed today, as outlined below.

In proactively meeting the growing needs of pharmaceutical companies both in Japan and overseas, and expanding business as the platform to manufacture pharmaceutical products, CMIC aims to enhance patients’ Personal Health Value by strengthening our formulation development technologies.

1.Outline of the Subsidiary (Joint Venture) and Issuance of New Shares through Third-Party Allocation

(1) Company NameCMIC CMO Co., Ltd.
(2) HeadquartersHamamatsucho Building, 1-1-1 Shibaura, Minato-ku, Tokyo
(3) Name and Title of RepresentativeMakoto Matsukawa, Representative Director and CEO
(4) Business DescriptionManufacturing, import/export and sales of pharmaceutical products
(5) FoundedOctober 16, 2009
(6) Total value of new shares issued8.5 billion JPY
(7) The allotted partyDevelopment Bank of Japan Inc.
(8) Payment dateJuly 2 2018
(9) Share-holding before capital increaseCMIC 100.0%
(10) Share-holding after capital increaseCMIC 50.4%, DBJ 49.6%